Dr. Sandra Black
Dr. Rick Swartz
Brain Challenges: Aging and Stroke
November 28th, 1:00-3:00 pm
As our population ages and we face a tsunami of brain disorders, we need to better understand the inner workings of the brain to develop more effective forms of prevention and treatment. Internationally renowned researcher Dr. Sandra Black discusses the aging process of the brain and the connection to blood vessel health, and colleague Dr. Rick Swartz explores how our understanding of the brain is leading to novel and more effective treatments for stroke patients.
Bio - Dr. Sandra Black
Dr. Sandra Black is an internationally renowned cognitive and stroke neurologist who holds the Brill Chair in Neurology at the University of Toronto and Sunnybrook Health Sciences Centre. A leading clinical trials researcher, she is the director of the Hurvitz Brain Sciences Research Program at Sunnybrook Research Institute, Sunnybrook site director of the Canadian Partnership for Stroke Recovery and the executive director of the Toronto Dementia Research Alliance. She has authored/co‐authored over 450 papers in a 25‐year career that has bridged dementia and stroke research, using neuroimaging to study brain behaviour relationships, with a recent focus on interactions of Alzheimer’s and silent stroke disease. In 2012 she was elected to the Royal Society of Canada and received the Order of Ontario, and in 2015 she was appointed an Officer to the Order of Canada for her contributions to Alzheimer’s disease, stroke and vascular dementia.
Bio - Dr. Rick Swartz
Dr. Rick Swartz is a stroke neurologist at Sunnybrook Health Sciences Centre, director of the Sunnybrook Stroke Research Unit, medical director of the North‐East GTA Regional Stroke Network, assistant professor, Neurology, University of Toronto and director of the U of T Stroke Program. His clinical specialty is stroke neurology, with a focus on stroke in the young, stroke in pregnancy, intracranial vascular diseases, and the functional consequences of stroke including vascular cognitive impairment. His research focuses on improving functional impairment in stroke patients – from hyperacute clinical trials to long‐term complications, with a focus on intracranial vascular diseases.